脑部健康补充品的全球市场:市场规模 - 各年龄层,各产品,各补充品形态,各用途,各销售管道,各地区展望,竞争策略,各市场区隔预测(~2032年)
市场调查报告书
商品编码
1170430

脑部健康补充品的全球市场:市场规模 - 各年龄层,各产品,各补充品形态,各用途,各销售管道,各地区展望,竞争策略,各市场区隔预测(~2032年)

Brain Health Supplements Market Size- By Age Group, By Product, By Supplement Form, By Application, By Sales Channel- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球脑部健康补充品的市场规模,预计至2032年达到174亿1,000万美元,以8.53%的年复合成长率成长。

由于人们的心理和情绪健康状况下降,COVID-19流行病对市场产生积极影响并增加消费者需求。随着第二波COVID-19促使消费者在日常生活中服用膳食补充剂以保护自己免受严重呼吸系统综合症的侵害,对大脑健康补充剂的需求显着增加。

本报告提供全球脑部健康补充品市场相关调查,市场动态,市场变数与展望,各年龄层、产品、补充品形态、用途、销售管道、地区的市场分析,企业简介等相关资讯。

目录

第1章 简介

  • 调查范围
  • 市场区隔分析

第2章 调查手法

  • 调查资料来源
  • 市场规模的估计
  • 资料的三角测量

第3章 摘要整理

第4章 市场动态

  • 促进因素,阻碍因素,机会,课题的分析
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
  • 全球脑部健康补充品市场上COVID-19的影响

第5章 市场变数与展望

  • SWOT分析
    • 优势
    • 弱点
    • 机会
    • 威胁
  • PESTEL分析
    • 政治形势
    • 经济形势
    • 社会形势
    • 技术形势
    • 环境形势
    • 法律上的形势
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 替代品的威胁
    • 新加入厂商的威胁
    • 竞争企业间的敌对关係
  • 热图分析

第6章 全球脑部健康补充品市场:各年龄层(2019年~2032年(100万美元))

  • 成人
  • 老年人
  • 儿童

第7章 全球脑部健康补充品市场:各产品(2019年~2032年(100万美元))

  • 药草萃取物
    • 过长沙
    • 姜黄素
    • 银杏
    • 高丽人参
    • 猴头菇
    • 其他
  • 维生素和矿物质
    • 维他命B
    • 维他命C、E
    • 其他
  • 天然分子
    • Acetyle-i-carnitine
    • Alphagpc
    • 胞磷胆碱
    • 二十二碳六烯酸
    • Huperzine A
    • 其他

第8章 全球脑部健康补充品市场:各补充品形态(2019年~2032年(100万美元))

  • 胶囊
  • 锭剂
  • 其他

第9章 全球脑部健康补充品市场:各用途(2019年~2032年(100万美元))

  • 不安
  • 注意力、集中力
  • 长寿、抗老化
  • 记忆力增强
  • 心情、忧郁症
  • 睡眠、復苏

第10章 全球脑部健康补充品市场:各销售管道(2019年~2032年(100万美元))

  • 药局
  • 网路商店
  • 超级市场、大卖场
  • 其他

第11章 全球脑部健康补充品市场:各地区(2019年~2032年(100万美元))

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的亚太地区
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中东、非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯联合大公国
    • 其他的中东、非洲

第12章 企业简介

  • Adisseo
    • 企业概要
    • 财务展望
    • 产品概要
    • 最近的开发
  • ADM
  • AlternaScript
  • BASF SE
  • BTSA Biotechnologias Aplicadas S.L.
  • DSM
  • Farbest Brands
  • Glanbia PLC
  • HVMN Inc.
  • Intelligent Labs
  • Lonza Group
  • Natural Factors Nutritional Product Ltd.
  • NOW Foods
  • Onnit Labs Inc.
  • Peak Nootropics
  • Purelife Bioscience Co. Ltd.
  • Rabar Pty Ltd.
  • Reckitt Benckiser Group PLC
  • SternVitamin GmbH & Co. KG
  • Teva Pharmaceutical Ltd.
简介目录
Product Code: PHAR2212

Global Brain Health Supplements Market Overview:

According to SPER Market Research, the Global Brain Health Supplements Market is estimated to reach USD 17.41 billion by 2032 with a CAGR of 8.53%.

Natural substances found in brain health supplements have advantageous impacts on the brain. These dietary supplements, which come in the form of herbal extracts in capsules, pills, and powders, assist healthy individuals in enhancing their memory, creativity, attention, motivation, and alertness. It has been demonstrated that herbs like withania somnifera and bacopa monniera enhance brain function. Additionally, B and C vitamins are good for the functioning of the nerves and brain. Supplements are goods that are utilised to correct and strengthen any kind of physical deficiencies in people. Supplements are available to consumers as tablets, capsules, soft gels, powders, or liquids. The type of supplements, such as herbal supplements and natural supplements, can be used to categorise them.

Impact of COVID-19 on the Global Brain Health Supplements Market:

Due to people's declining mental and emotional health, the COVID-19 epidemic has had a favorable effect on the market and increased consumer demand for these items. Due to the uncertainties surrounding the ongoing COVID-19 lawsuits around the world, people are spending more money on products that support memory. The epidemic has caused a disruption in the supply chain, affecting both the supply of finished goods and the acquisition of raw materials. The production of supplements has been somewhat impeded as a result of the bans that several nations have placed on the import and export of raw materials. The demand for brain health supplements has significantly increased as a result of the coronavirus 2nd wave, which has motivated consumers to consume dietary supplements in their everyday lives to protect themselves from severe respiratory syndrome coronavirus.

Scope of the Report:

Report Metric Details:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Age Group, By Product, By Supplement Form, By Application, By Sales Channel
  • Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Companies Covered: Adisseo, ADM, AlternaScript, BASF SE, BTSA Biotechnologias Aplicadas S.L., DSM, Farbest Brands, Glanbia PLC, HVMN Inc., Intelligent Labs, Lonza Group, Natural Factors Nutritional Products Ltd., NOW Foods, Onnit Labs, Inc., Peak Nootropics, Purelife Bioscience Co., Ltd., Rabar Pty Ltd., Reckitt Benckiser Group PLC., SternVitamin GmbH & Co. KG, Teva Pharmaceutical Industries Ltd

Global Brain Health Supplements Market Segmentation:

  • By Age Group: Based on the Age Group, Global Brain Health Supplements Market is segmented as; Adults, Elderly and Kids.
  • By Product: Based on the Product, Global Brain Health Supplements Market is segmented as; Herbal Extracts (Bacopa monnieri, Curcumin, Ginkgo bilola, Ginseng, Lions mane, Others), Vitamins and Minerals (Vitamin B, Vitamin C & E, Others), Natural Molecules (Acetyle-i-carnitine, Alpha gpc, Citicoline, Docosahexaenoic acid, Huperzine A, others).
  • By Supplement Form: Based on the Supplement Form, Global Brain Health Supplements Market is segmented as; Capsules, Tablets and Others.
  • By Application: Based on the Application, Global Brain Health Supplements Market is segmented as; Anxiety, Attention and Focus, Longevity and Anti-aging, Memory Enhancement, Mood and Depression, Sleep and Recovery.
  • By Sales Channel: Based on the Sales Channel, Global Brain Health Supplements Market is segmented as; Drug Stores, Online Stores, Supermarkets and Hypermarkets and Others.
  • By Region: In recent years, North America has contributed the most to the market. The demand for the product in North America is being driven by consumers' increased concerns about their mental health. Adults in the United States regularly use nutritional supplements containing vitamins, minerals, and botanical components to boost their performance, energy, and mental clarity. These trends are probably going to accelerate the market expansion in the nation. According to the American Psychological Association, loneliness and uncertainty about the future are significant stressors for adolescents and young adults in America. As a result, it is anticipated that more and more adults will take supplements for brain health in order to maintain proper brain function.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Brain Health Supplements Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Brain Health Supplements Market, By Age Group, 2019-2032 (USD Million)

  • 6.1. Adults
  • 6.2. Elderly
  • 6.3. Kids

7. Global Brain Health Supplements Market, By Product, 2019-2032 (USD Million)

  • 7.1. Herbal Extracts
    • 7.1.1. Bacopa monnieri
    • 7.1.2. Curcumin
    • 7.1.3. Ginkgo bilola
    • 7.1.4. Ginseng
    • 7.1.5. Lions mane
    • 7.1.6. Others
  • 7.2. Vitamins and Minerals
    • 7.2.1 Vitamin B
    • 7.2.2 Vitamin C & E
    • 7.2.3 Others
  • 7.3. Natural Molecules
    • 7.3.1 Acetyle-i-carnitine
    • 7.3.2 Alpha gpc
    • 7.3.3 Citicoline
    • 7.3.4 Docosahexaenoic acid
    • 7.3.5 Huperzine A
    • 7.3.6 others

8. Global Brain Health Supplements Market, By Supplement Form, 2019-2032 (USD Million)

  • 8.1. Capsules
  • 8.2. Tablets
  • 8.3. Others

9. Global Brain Health Supplements Market, By Application, 2019-2032 (USD Million)

  • 9.1. Anxiety
  • 9.2. Attention and Focus
  • 9.3. Longevity and Anti-aging
  • 9.4. Memory Enhancement
  • 9.5. Mood and Depression
  • 9.6. Sleep and Recovery

10. Global Brain Health Supplements Market, By Sales Channel, 2019-2032 (USD Million)

  • 10.1 Drug Stores
  • 10.2 Online Stores
  • 10.3 Others
  • 10.4 Supermarkets and Hypermarkets

11. Global Brain Health Supplements Market, By Region, 2019-2032 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Adisseo
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 ADM
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 AlternaScript
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 BASF SE
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 BTSA Biotechnologias Aplicadas S.L.
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 DSM
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 Farbest Brands
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Glanbia PLC
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 HVMN Inc.
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 Intelligent Labs
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Lonza Group
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Natural Factors Nutritional Product Ltd.
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 NOW Foods
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 Onnit Labs Inc.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Peak Nootropics
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 Purelife Bioscience Co. Ltd.
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Rabar Pty Ltd.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Reckitt Benckiser Group PLC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 SternVitamin GmbH & Co. KG
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Teva Pharmaceutical Ltd.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments